Infection, Inflammation, and Immunity in Sepsis

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Sepsis pathogenesis involves innate and adaptive immunity.
• Cytoplasmic DNA/RNA triggers inflammation via the cGAS-STING pathway, releasing cytokines like IL-6 and TNF-α.
• These cytokines activate phospholipase A2 (PLA2), releasing polyunsaturated fatty acids (PUFAs) crucial for inflammation resolution.

Purpose of the Study:

• To elucidate the role of PUFAs and the cGAS-STING pathway in sepsis.
• To investigate the impact of PUFA deficiency on inflammatory responses.
• To explore potential therapeutic strategies for sepsis and radiation-induced inflammation.

Main Methods:

• The study focuses on the molecular mechanisms linking immune triggers to inflammatory cytokine release.
• It examines the role of PLA2 in PUFA production and their subsequent effect on the cGAS-STING pathway.
• It analyzes the impact of pro-inflammatory cytokines and corticosteroids on desaturase activity and PUFA synthesis.

Main Results:

• Failure to eliminate cytoplasmic DNA/RNA activates the cGAS-STING pathway, inducing IL-6, TNF-α, and IFNs.
• Activated PLA2 releases PUFAs (GLA, AA, EPA, DHA), which normally suppress cGAS-STING and resolve inflammation.
• Pro-inflammatory cytokines and corticosteroids inhibit desaturases, decreasing PUFA formation and hindering inflammation resolution, thus promoting sepsis.

Conclusions:

• Altered PUFA concentrations and impaired cGAS-STING suppression contribute to sepsis onset.
• Similar mechanisms are implicated in radiation-induced inflammation.
• Therapeutic strategies involving PUFAs, corticosteroids, and cytokine inhibitors may mitigate sepsis and radiation damage.